Cannabinoids in the Orthopedic Setting: A Literature Review

Author:

Carreira Dominic S.,Garden Steven,Huffman Allison,Ueland Thomas

Abstract

Public interest in the analgesic potential of cannabinoids has grown, but there is no consensus regarding orthopedic applications. Available evidence was identified for cannabinoid use in arthritis, neuropathic pain, fibromyalgia, multiple sclerosis, and postoperative pain. Extracted information included the risks of preoperative use, associations with opioid dependence, and surgical complications. There is limited evidence for therapeutic benefit of cannabinoids in rheumatoid arthritis and fibromyalgia. Cannabinoids are not indicated for postoperative pain. Preoperative unregulated use has been linked with postoperative opioid dependence. Cannabinoids may be considered a second- or third-line treatment for analgesia for some orthopedic pathologies. [ Orthopedics . 2022;45(4):e183–e189.]

Publisher

SLACK, Inc.

Subject

Orthopedics and Sports Medicine,Surgery

Reference64 articles.

1. Osteoarthritis prevalence and modifiable factors: a population study

2. Crombie IK, Croft PR, Linton SJ, Leresche L, Korff MV. Epidemiology of Pain: A Report of the Task Force on Epidemiology. IASP Press; 1999.

3. Systematic review of persistent pain and psychological outcomes following traumatic musculoskeletal injury

4. Opioids should be last resort to treat chronic pain, says draft CDC guideline

5. U.S. Food and Drug Administration. FDA regulation of cannabis and cannabis-derived products: Q&A. U.S. Food and Drug Administration. Accessed February 8 2022. https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3